Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assessment of response to therapy using conventional imaging.

Literature DB >> 12664137

Assessment of response to therapy using conventional imaging.

Abstract

The response of lymphoma to treatment is usually documented using cross-sectional imaging. The definitions of response and the changes seen on CT and MRI in the chest and abdomen are well recognised. However, the appearances of residual masses are more variable and features that may help in diagnosis will be included in this review.

Entities: Disease

Mesh：

Year: 2003 PMID： 12664137 DOI： 10.1007/s00259-003-1162-9

Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236

46 in total

Review 1. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Authors: B D Cheson; S J Horning; B Coiffier; M A Shipp; R I Fisher; J M Connors; T A Lister; J Vose; A Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; J O Armitage; W Carter; R Hoppe; G P Canellos
Journal: J Clin Oncol Date: 1999-04 Impact factor: 44.544

2. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.

Authors: G Jerusalem; Y Beguin; M F Fassotte; F Najjar; P Paulus; P Rigo; G Fillet
Journal: Blood Date: 1999-07-15 Impact factor: 22.113

3. Post-therapy CT-detected mass in lymphoma patients: is it viable tissue?

Authors: E Lewis; M E Bernardino; P G Salvador; F F Cabanillas; P A Barnes; J L Thomas
Journal: J Comput Assist Tomogr Date: 1982-08 Impact factor: 1.826

4. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.

Authors: B Coiffier; C Gisselbrecht; R Herbrecht; H Tilly; A Bosly; N Brousse
Journal: J Clin Oncol Date: 1989-08 Impact factor: 44.544

5. Thoracoscopy or CT-guided biopsy for residual intrathoracic masses after treatment of lymphoma.

Authors: D Gossot; P Girard; E de Kerviler; P Brice; J D Rain; T Leblanc; D Grunenwald
Journal: Chest Date: 2001-07 Impact factor: 9.410

6. Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma.

Authors: M Hill; D Cunningham; D MacVicar; A Roldan; J Husband; R McCready; J Mansi; S Milan; T Hickish
Journal: J Clin Oncol Date: 1993-11 Impact factor: 44.544

7. Restaging laparotomy in the management of the non-Hodgkin lymphomas.

Authors: J Z Fuks; J Aisner; P H Wiernik
Journal: Med Pediatr Oncol Date: 1982

8. Radiation fibrosis: differentiation from recurrent tumor by MR imaging.

Authors: H S Glazer; J K Lee; R G Levitt; J P Heiken; D Ling; W G Totty; D M Balfe; B Emani; T H Wasserman; W A Murphy
Journal: Radiology Date: 1985-09 Impact factor: 11.105

9. Residual tumor masses following treatment for advanced histiocytic lymphoma. Diagnostic and therapeutic implications.

Authors: F M Stewart; B R Williamson; D J Innes; C E Hess
Journal: Cancer Date: 1985-02-01 Impact factor: 6.860

10. Outcome of residual mediastinal masses of thoracic lymphomas in children: impact on management and radiological follow-up strategy.

Authors: H Brisse; H Pacquement; E Burdairon; C Plancher; S Neuenschwander
Journal: Pediatr Radiol Date: 1998-06

5 in total

5. An uncommon clinical presentation of retroperitoneal non-Hodgkin lymphoma successfully treated with chemotherapy: a case report.

Authors: Chiara Fulignati; Pietro Pantaleo; Greta Cipriani; Marianna Turrini; Rosalia Nicastro; Roberto Mazzanti; Bruno Neri
Journal: World J Gastroenterol Date: 2005-05-28 Impact factor: 5.742